| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/24/2001 | US6265175 Incubating components comprising neuroblast and composition to be tested for ability to stimulate or inhibit proliferation or differentiation of the neuroblast to allow composition to bind to neuroblast, culturing, detecting effect |
| 07/24/2001 | US6264992 Gelled aqueous protein hydrolyzate |
| 07/24/2001 | US6264944 Mechanically elongated neuronal cells |
| 07/24/2001 | US6264943 Parkinson's disease |
| 07/24/2001 | US6264940 Antitumor, anticancer agent |
| 07/24/2001 | US6264646 Method for preventing and reversing atherosclerosis in mammals |
| 07/19/2001 | WO2001051631A2 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 07/19/2001 | WO2001051617A1 Monocyte-derived dendritic cell subsets |
| 07/19/2001 | WO2001051616A2 Techniques for growth and differentiation of human pluripotent stem cells |
| 07/19/2001 | WO2001051611A1 Cell production |
| 07/19/2001 | WO2001051610A1 Ectoderm cell production |
| 07/19/2001 | WO2001051608A2 Hybrid cells obtainable from antigen presenting cells |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051453A1 Racemic and optically pure metabolites of sibutramine, their preparation, compositions comprising them and their use as dopamine reuptake inhibitors |
| 07/19/2001 | WO2001051093A2 METHODS OF INCREASING THE GLUCOSE RESPONSIVENESS OF PANCREATIC β-CELLS |
| 07/19/2001 | WO2001051074A1 Methods for treating pancreatic disorders |
| 07/19/2001 | WO2001051068A1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures |
| 07/19/2001 | WO2001051066A2 Reduction in bacterial colonization by administering bacteriophage compositions |
| 07/19/2001 | WO2001051062A1 Compositions for enhancing the immune response |
| 07/19/2001 | WO2001051048A1 Use of epigallocatechin-gallate for inhibiting angiogenesis |
| 07/19/2001 | WO2001051027A2 Polymer blends as biodegradable matrices for preparing biocomposites |
| 07/19/2001 | WO2001051014A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | WO2001050881A2 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 07/19/2001 | WO2001050873A1 Thickened oil compositions of edible oil |
| 07/19/2001 | WO2001050872A2 Method for produce sanitation using bacteriophages |
| 07/19/2001 | WO2001050866A2 Method and device for sanitation using bacteriophages |
| 07/19/2001 | WO2001050848A2 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | WO2001014414A3 Human abc2 transporter and uses thereof |
| 07/19/2001 | WO2001013933A3 Agents for the enhanced oxygen delivery in mammals |
| 07/19/2001 | WO2001005941A3 Storage of microorganisms, cells and tissue |
| 07/19/2001 | WO2001005820A3 Method for down-regulating gdf-8 activity |
| 07/19/2001 | WO2001004271A3 Respiratory syncytial viruses expressing immune modulatory molecules |
| 07/19/2001 | WO2000077043A3 Dna vaccines for pets and sport animals |
| 07/19/2001 | WO2000075275A3 Bioreactor design and process for engineering tissue from cells |
| 07/19/2001 | WO2000046351A3 Platform for the differentiation of cells |
| 07/19/2001 | WO2000040229A3 Synergistic tumorcidal response induced by histamine |
| 07/19/2001 | WO2000023573A9 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
| 07/19/2001 | US20010008881 Method for the augmentation of gene expression |
| 07/19/2001 | US20010008757 Synthetic media for blood components |
| 07/19/2001 | US20010008221 Blood processing systems and methods using apparent hematocrit as a process control parameter |
| 07/19/2001 | DE10101543A1 Enhancing the antitumor activity of an amygdalin-containing material, especially loquat kernels, comprises roasting the material with far infrared radiation and fermenting it with microorganisms |
| 07/19/2001 | CA2823768A1 Hybrid cells |
| 07/19/2001 | CA2430501A1 Method for produce sanitation using bacteriophages |
| 07/19/2001 | CA2430500A1 Method and device for sanitation using bacteriophages |
| 07/19/2001 | CA2430498A1 Reduction in bacterial colonization by administering bacteriophage compositions |
| 07/19/2001 | CA2397707A1 Compositions for enhancing the immune response |
| 07/19/2001 | CA2397292A1 Cell production |
| 07/19/2001 | CA2397068A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2397030A1 Methods for treating pancreatic disorders |
| 07/19/2001 | CA2396950A1 Racemic and optically pure metabolites of sibutramine, their preparation, compositions comprising them and their use as dopamine reuptake inhibitors |
| 07/19/2001 | CA2396247A1 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | CA2396071A1 Thickened oil compositions of edible oil |
| 07/19/2001 | CA2394831A1 Monocyte-derived dendritic cell subsets |
| 07/19/2001 | CA2366621A1 Use of epigallocatechin-gallate for inhibiting angiogenesis |
| 07/18/2001 | EP1115889A1 Methods to selectively inactivate viruses in biological compositions |
| 07/18/2001 | EP1115879A1 Retroviral particles protected against complement mediated destruction |
| 07/18/2001 | EP1115878A1 Recombinant celo virus and celo virus dna |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115859A2 Hairpin hybridizer molecules for modulation of gene expression |
| 07/18/2001 | EP1115857A1 Use of specific hybrid promoters for controlling tissue expression |
| 07/18/2001 | EP1115851A1 Method of screening for large offspring syndrome |
| 07/18/2001 | EP1115432A1 Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge |
| 07/18/2001 | EP1115408A2 Oxihumic acid and its use in the treatment of various conditions |
| 07/18/2001 | EP1115286A1 Methods for treating or preventing viral infections and associated diseases |
| 07/18/2001 | EP0752869B1 Cells with multiple altered epitopes on a surface antigen for use in transplantation |
| 07/18/2001 | EP0671958B1 Apparatus for the treatment of tumors by selective protein depletion |
| 07/18/2001 | EP0575555B1 Protein-induced morphogenesis |
| 07/18/2001 | CN1304452A Attenuated pestiviruses |
| 07/18/2001 | CN1304313A Lactic acid bacterium-containing compositions, drugs and foods |
| 07/18/2001 | CN1304312A Composition and method for treatment and preventing of arthritis and/or autoimmune diseases |
| 07/18/2001 | CN1304309A Semi-synthetic ecteinascidins |
| 07/18/2001 | CN1303860A Preparation method of negative acute stage nickel brown protein |
| 07/18/2001 | CN1303703A External powder for curing rheumatism involving bone and its preparation method |
| 07/18/2001 | CN1303702A Bone-knitting medicine and its preparation method |
| 07/18/2001 | CN1303692A Toxin-discharging liver-fortifying medicine |
| 07/18/2001 | CN1303685A Production method of leifengshi Zhitong wan for curing rheumatoid disease |
| 07/18/2001 | CN1303682A Preparation method of medicine for curing surgical diseases of traditional Chinese medicine |
| 07/18/2001 | CN1303678A Production process of bio-active forest frog's oviduct soft capsule |
| 07/18/2001 | CN1068523C Medicine for curing cancer and its preparing technology |
| 07/18/2001 | CA2296997A1 Treatment of congestive heart failure |
| 07/17/2001 | US6262236 Fibrin sealant compositions and methods for utilizing same |
| 07/17/2001 | US6262032 Method of destroying hyperproliferative cells by combined p53 and taxoid treatment |
| 07/17/2001 | US6262026 Chimeric proteins for use in transport of a selected substance into cells |
| 07/17/2001 | US6262018 Hypersensitive response elicitor from Erwinia amylovora and its use |
| 07/17/2001 | US6262017 Peptides for altering osteoblast adhesion |
| 07/17/2001 | US6262016 Transferrin receptor genes |
| 07/17/2001 | US6261841 Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells |
| 07/17/2001 | US6261839 Method for the induction of a NK cell-mediated immune response |
| 07/17/2001 | US6261832 Automated cell processor |
| 07/17/2001 | US6261807 Method for preparing a recombinant adenovirus genome |
| 07/17/2001 | US6261791 Method for diagnosing cancer using specific PSCA antibodies |
| 07/17/2001 | US6261587 Contacting with matrix containing gelatin and nitric acid inhibitor |
| 07/17/2001 | US6261572 In situ administering |
| 07/17/2001 | US6261557 Arginine decomposing enzyme therapeutic composition |
| 07/17/2001 | US6261555 Reovirus for the treatment of neoplasia |
| 07/17/2001 | US6261554 Compositions for targeted gene delivery |
| 07/17/2001 | US6261551 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
| 07/17/2001 | CA2331167A1 Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method for assessing antitumor substance containing amygdalin |
| 07/17/2001 | CA2126911C Isolation and structure of spongistatin 2, spongistatin 3, spongistatin 4 and spongistatin 6 |